Cormorant Asset Management »

Engene Holdings shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Engene Holdings (ENGN) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.4M 1.0M 9.43
2024-03-31 $17M 1.0M 16.95

More positions owned by Cormorant Asset Management

Moonlake Immunotherapeutics Class A Ord (MLTX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Arcellx Common Stock (ACLX)
Vaxcyte (PCVX)
Longboard Pharmaceuticals In (LBPH)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Merus N V (MRUS)
Bridgebio Pharma (BBIO)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Janux Therapeutics (JANX)
Axsome Therapeutics (AXSM)

View all positions for Cormorant Asset Management

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
VR Adviser
Blue Owl Capital Holdings
BVF
Deep Track Capital
Logos Global Management
Franklin Resources
Omega Fund Management
Cormorant Asset Management
Henderson Group
Soleus Capital Management
Boxer Capital
Marshall Wace
Point72 Asset Management
Sr One Capital Management

View all funds holding Engene Holdings